Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Rowe

Showing results (391-400 of 504) with videos related to

Pageof 51
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
EJNMMI Research|October 4, 2017
Correlation of <sup>99m</sup>Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expressionSteven P Rowe, Michael A Gorin, Lilja B Solnes, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
PET Clinics|January 10, 2024
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract CancersJorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, et al.
Pageof 51

Showing results (391-400 of 504) with videos related to

Sort By:
Pageof 51
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 29, 2024
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PETAjay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Molecular Imaging|June 30, 2020
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [<sup>124</sup>I]FIAU PET/CTSteve Y Cho, Steven P Rowe, Sanjay K Jain, et al.
Diagnostic and Interventional Imaging|August 2, 2025
Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor typesJorge D Oldan, Anurag Anugu, Md Zobaer Islam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand TherapyPhilipp E Hartrampf, Patrick W Mihatsch, Anna Katharina Seitz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2022
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerPhilipp E Hartrampf, Franz-Xaver Weinzierl, Andreas K Buck, et al.
EJNMMI Research|October 4, 2017
Correlation of <sup>99m</sup>Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expressionSteven P Rowe, Michael A Gorin, Lilja B Solnes, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
PET Clinics|January 10, 2024
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract CancersJorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, et al.
Pageof 51